Skip to main content

Advertisement

SpringerLink
Log in

Symmetrical Drug-Related Intertriginous and Flexural Exanthem-Like Eruption Post-COVID-19 Vaccination: A Case Report and Review of the Literature

  • REVIEW
  • Published:
Current Dermatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

SDRIFE (Symmetrical drug-related intertriginous and flexural exanthema) is type IV hypersensitivity drug-related skin eruption. Numerous drugs have previously been associated with SDRIFE; however few cases associated with the coronavirus disease 2019 (COVID-19) vaccine have been reported. Here, we present a case in which SDRIFE was generated following administration of the CoronaVacTM (SinoVac Biotech Corporation) vaccine. A literature review was also conducted to summarize the various cases of SDRIFE induced by the coronavirus disease 2019 (COVID-19) vaccine.

Recent Findings

SDRIFE is a rare complication of COVID-19 vaccines. Here, we reviewed all 14 cases reported in the literature, along with our own case. Three cases, including ours, have been reported with the CoronaVacTM vaccine, a purified, inactivated antigen vaccine produced by the SinoVac Biotech Corporation.

Summary

SDRIFE-like eruptions are thought to constitute a delayed type IV immune response to COVID-19 vaccines. However, further studies are required to determine the possible underlying mechanisms involved. The use of COVID-19 vaccines is affecting an increasing number of people worldwide. Therefore, clinicians should be informed of any adverse reactions that may occur. Knowing these reactions can help us illuminate the possible mechanisms of the COVID-19 and other COVID-19 vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

No datasets were generated or analysed during the current study.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Winnicki M, Shear NH. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions. Am J Clin Dermatol. 2011;12(3):171–80. https://doi.org/10.2165/11539080-000000000-00000.

    Article  PubMed  Google Scholar 

  2. •• Orenay OM, Balta I, Yigit D, Eksioglu M. Systemic drug-related intertriginous and flexural exanthema like eruption after CoronaVac vaccine. J Eur Acad Dermatol Venereol. 2021;35(10):e634–5. https://doi.org/10.1111/jdv.17454. This article is important because it is the first to report the development of SDRIFE-like eruption after COVID vaccination.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hai J, Shawa H, Kim-Lim P, et al. Systemic drug-related intertriginous and flexural exanthema induced by the Pfizer-BioNTech COVID-19 vaccine: A report of 2 cases. JAAD Case Rep. 2021;18:57–60. https://doi.org/10.1016/j.jdcr.2021.10.016.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bellinato F, Maurelli M, Gisondi P, Girolomoni G. Cutaneous adverse reactions associated with SARS-CoV-2 vaccines. J Clin Med. 2021;10(22):5344. https://doi.org/10.3390/jcm10225344. Published 2021 Nov 16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lim PN, Wylie G. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination. Clin Exp Dermatol. 2022;47(1):175–6. https://doi.org/10.1111/ced.14898.

    Article  CAS  PubMed  Google Scholar 

  6. Hong JK, Shin SH, Yoo KH, Li K, Seo SJ. Symmetric drug-related intertriginous and flexural exanthema-like eruption related to coronavirus disease 2019 vaccine. Contact Dermatitis. 2022;87(1):91–3. https://doi.org/10.1111/cod.14092.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Manaa A, Ziv M, Krausz J, Dodiuk-Gad RP. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination. Dermatol Ther. 2022;35(7):e15546. https://doi.org/10.1111/dth.15546.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sandhu J, Katha M, Gupta SK. Covishield™ (ChAdOx1 nCoV-19) Vaccine-Induced Systemic Drug-Related Intertriginous and Flexural Exanthema in a Young Girl: A Case Report and Literature Review. Indian J Dermatol. 2022;67(6):783–5. https://doi.org/10.4103/ijd.ijd_511_22.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lahouel I, Ben Salah N, Ben Fadhel N, et al. Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2022;36(8):e597–9. https://doi.org/10.1111/jdv.18108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Camela E, Scalvenzi M, Megna M, et al. Reply to “A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination” by Manaa et al. Dermatol Ther. 2022;35(12):e15881. https://doi.org/10.1111/dth.15881.

    Article  PubMed  Google Scholar 

  11. Çakıcı ÖA, Güder S, Salman A, Ergun T. Symmetrical drug-related intertriginous and flexural exanthema-like eruption: An addition to the spectrum of coronavirus disease 2019-related cutaneous findings. Indian J Dermatol Venereol Leprol. 2022;88(6):814–6. https://doi.org/10.25259/IJDVL_165_2022.

    Article  PubMed  Google Scholar 

  12. Andersen KE, Hjorth N, Menné T. The baboon syndrome: systemically induced allergic contact dermatitis. Contact Dermatitis. 1984;10(2):97–100. https://doi.org/10.1111/j.1600-0536.1984.tb00343.x.

    Article  CAS  PubMed  Google Scholar 

  13. Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis. 2004;51(5–6):297–310. https://doi.org/10.1111/j.0105-1873.2004.00445.x.

    Article  PubMed  Google Scholar 

  14. • Harbaoui S, Litaiem N. Symmetrical Drug-Related Intertriginous and Flexural Exanthema. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. This book provides up-to-date and detailed information on the etiology, epidemiology, pathophysiology, histopathology, evaluation, treatment and management, differential diagnosis, prognosis, complications, and patient education in symmetrically drug-related intertriginous and flexural exanthema.

    Google Scholar 

  15. Schuler AM, Smith EH, Chaudet KM, et al. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature. J Cutan Pathol. 2021;48(12):1471–9. https://doi.org/10.1111/cup.14090.

    Article  PubMed  Google Scholar 

  16. Heck J, Stichtenoth DO, Mettin R, Jöckel J, Bickel C, Krichevsky B. Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature. Eur J Clin Pharmacol. 2021;77(1):141–4. https://doi.org/10.1007/s00228-020-02955-4.

    Article  CAS  PubMed  Google Scholar 

  17. Keshavamurthy C, Fibeger E, Virata A, Bansal P. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with Infliximab: a case-based review. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with Infliximab: a case-based review. ARP Rheumatol. 2022;1(4):322–7.

    PubMed  Google Scholar 

  18. Bonamigo RR, Bottega GB, Staub FL, Almeida RO, Werka HMG. Bullous SDRIFE and Covid-19. Int J Dermatol. 2022;61(3):372–4. https://doi.org/10.1111/ijd.16012.

    Article  CAS  PubMed  Google Scholar 

  19. Chicharro P, Rodríguez-Jiménez P, Muñoz-Aceituno E, De Argila D, Muñoz-Hernández P, Llamas-Velasco M. SDRIFE-like rash associated with COVID-19, clinicopathological correlation. Australas J Dermatol. 2021;62(1):88–9. https://doi.org/10.1111/ajd.13444.

    Article  PubMed  Google Scholar 

  20. Bevilaqua M, Ribolli GB, Luzzatto L, Fernandes JC, Pasqualotto AC, Bonamigo RR. SDRIFE-like rash in COVID-19 patient: drug reaction or another cutaneous manifestation of SARS-CoV-2? Int J Dermatol. 2021;60(7):884–5. https://doi.org/10.1111/ijd.15537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Athira R, Hamsa L, Thomas N, Zacharias R. SDRIFE-Like Rash With COVID - 19. Indian Pediatr. 2022;59(2):168. https://doi.org/10.1007/s13312-022-2451-3.

    Article  CAS  PubMed  Google Scholar 

  22. Zenarola P, Gimma A, Lomuto M. Systemic contact dermatitis from thimerosal. Contact Dermatitis. 1995;32(2):107–8. https://doi.org/10.1111/j.1600-0536.1995.tb00756.x.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Ceyhan State Hospital, Adana, Turkey

    Cagdas Boyvadoglu

  2. Department of Dermatology, Faculty of Medicine, University of Erciyes, Kayseri, Turkey

    Salih Levent Cinar

Authors
  1. Cagdas Boyvadoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salih Levent Cinar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CB was involved in conceptualization, data curation, visualization, writing-review, and editing. SLC was involved in conceptualization, and editing.

Corresponding author

Correspondence to Cagdas Boyvadoglu.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boyvadoglu, C., Cinar, S.L. Symmetrical Drug-Related Intertriginous and Flexural Exanthem-Like Eruption Post-COVID-19 Vaccination: A Case Report and Review of the Literature. Curr Derm Rep (2024). https://doi.org/10.1007/s13671-024-00426-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13671-024-00426-y

Keywords

Search

Navigation